Publication Name	World Journal of Diabetes
Manuscript ID	28870
Country	United States

Received	2016-07-19 09:59
Peer-Review Started	2016-07-21 14:18
To Make the First Decision	2016-09-05 09:12
Return for Revision	2016-09-05 17:00
Revised
Second Decision	2016-09-28 11:27
Accepted by Journal Editor-in-Chief	2016-09-29 10:48
Accepted by Executive Editor-in-Chief	2016-10-18 16:35
Articles in Press	2016-10-18 16:35
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2016-11-30 10:30
Publish the Manuscript Online	2016-12-09 09:12

ISSN	1948-9358 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Allergy
Manuscript Type	Minireviews
Article Title	Place of technosphere inhaled insulin in treatment of diabetes
Manuscript Source	Invited Manuscript
All Author List	Nasser Mikhail
Funding Agency and Grant Number
Corresponding Author	Nasser Mikhail, MD, Department of Medicine, OliveView-UCLA Medical Center, 14445 Olive View Dr, Sylmar, CA 91342, United States. nmikhail@dhs.lacounty.gov
Key Words	Afrezza; Efficacy; Safety; Technosphere insulin; Cough
Core Tip	Technosphere insulin is the only approved form of inhaled insulin. It is a short-acting insulin that can be taken with meals in patients with type 1 or type 2 diabetes. In this minireview, the author provides an appraisal of this new formulation of insulin to help determine its place in the management of diabetes.
Publish Date	2016-12-09 09:12
Citation	Mikhail N. Place of technosphere inhaled insulin in treatment of diabetes. World J Diabetes 2016; 7(20): 599-604
URL	http://www.wjgnet.com/1948-9358/full/v7/i20/599.htm
DOI	http://dx.doi.org/10.4239/wjd.v7.i20.599

Full Article (PDF)	WJD-7-599.pdf
Full Article (Word)	WJD-7-599.doc
Manuscript File	28870-Review.docx
Answering Reviewers	28870-Answering reviewers.pdf
Audio Core Tip	28870-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	28870-Conflict-of-interest statement.pdf
Copyright License Agreement	28870-Copyright assignment.pdf
Peer-review Report	28870-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	28870-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	28870-Scientific misconduct check.pdf
Scientific Editor Work List	28870-Scientific editor work list.pdf